Literature DB >> 15163137

Does a health plan effort to increase smokers' awareness of cessation medication coverage increase utilization and cessation?

Nina L Alesci1, Raymond G Boyle, Gestur Davidson, Leif I Solberg, Sanne Magnan.   

Abstract

PURPOSE: To test whether a mailing describing new coverage for smoking cessation medications increases benefit knowledge, utilization, and quitting.
METHODS: This randomized controlled trial assigned participants to benefit communication via (1) standard contract changes or (2) enhanced communication with direct-to-member postcards. A sample of 1930 self-identified smokers from two Minnesota health plans took surveys before and 1 year after the benefit's introduction. The follow-up response rate was 80%. A multilevel logistic estimator tested for differences in benefit knowledge and smoking behavior from baseline.
RESULTS: More enhanced than standard communication respondents knew about the benefit (39.0% vs. 22.2%, p < .0001) at follow-up. Groups did not differ on bupropion utilization (24.6% vs. 23.1%, p = .92); nicotine replacement therapy utilization (26.9% vs. 25.9%, p = .26), or cessation (12.8% vs. 15.6%, p = .32).
CONCLUSION: Although limited by the low intervention intensity and potential social desirability bias, information about new coverage alone does not appear to increase quitting behaviors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163137     DOI: 10.4278/0890-1171-18.5.366

Source DB:  PubMed          Journal:  Am J Health Promot        ISSN: 0890-1171


  4 in total

1.  Boosting population quits through evidence-based cessation treatment and policy.

Authors:  David B Abrams; Amanda L Graham; David T Levy; Patricia L Mabry; C Tracy Orleans
Journal:  Am J Prev Med       Date:  2010-03       Impact factor: 5.043

2.  Impact of Broadened Coverage of Smoking Cessation Treatments on Cardiovascular Disease.

Authors:  Paul A Fishman
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-12-01

3.  Use of a new comprehensive insurance benefit for smoking-cessation treatment.

Authors:  Marguerite E Burns; Marjorie A Rosenberg; Michael C Fiore
Journal:  Prev Chronic Dis       Date:  2005-09-15       Impact factor: 2.830

4.  Evaluation of a population-level strategy to promote tobacco treatment use among insured smokers: a pragmatic, randomized trial.

Authors:  Jennifer B McClure; Melissa L Anderson
Journal:  BMC Public Health       Date:  2018-02-08       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.